Arcellx, Inc. a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, announced

RK Pharma Inc, a vertically integrated pharmaceutical company today announced the successful completion of the acquisition of VGYAAN Pharmaceuticals LLC. The acquisition of VGYAAN Pharmaceuticals aligns strongly with our growth strategy

Oliva Therapeutics, LLC, a healthcare company focused on product commercialization, sales, marketing, distribution, and promotion, announced today a long-term partnership with Rio Biopharmaceuticals, Inc., a subsidiary of the EMS S/A Pharma

Astellas Pharma Inc. and Cullgen Inc. today announced a research collaboration and exclusive option agreement to discover multiple innovative protein degraders.

Eyebiotech Limited a clinical-stage ophthalmology biotechnology company, today announced the dosing of the first participants in its Phase 1b/2 AMARONE clinical trial in patients with diabetic

Future Fields, a pioneering biotechnology company that has built the world’s first synthetic biology system to use fruit flies for recombinant protein production, and Jenthera Therapeutics, a gene editing company focused on delivery of the CRISPR ribonucleoproteins

ACROBiosystems, through ACRO Certify and under its Aneuro brand, recently announced the launch of in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips. Together, two companies are committed to a collaborative

Veristat, a scientific-minded global clinical research organization, has acquired Scinopsis, a European medical writing consultancy with a 17-year track record of delivering regulatory

Lantern Pharma Inc. an artificial intelligence company developing targeted and transformative cancer therapies using its proprietary RADR® AI and machine learning platform with multiple

Cyclo Therapeutics, Inc. a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases,